Transcranial Magnetic Stimulation (TMS) for CRPS
Not Applicable
Completed
- Conditions
- Complex Regional Pain Syndrome (CRPS)
- Interventions
- Device: Transcranial Magnetic Stimulation (TMS)
- Registration Number
- NCT02067273
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this pilot study is to test the durability of response to Transcranial Magnetic Stimulation (TMS) for the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS for varying lengths of time in a pilot study to investigate what the clinical impact.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Age 18 or older
- Diagnosis of CRPS (complex regional pain syndrome)
- Average pain level reported on Numerical Rating Scale meets entry criteria
- Ability to perform the experimental task and procedures.
Read More
Exclusion Criteria
- MRI contraindication (metal implants or devices, claustrophobia)
- TMS Contraindication (eg metal implant or devices near the site of stimulation)
- History of epilepsy
- History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- Neurologic illness that would interfere with brain integrity
- Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- Currently pregnant or planning to become pregnant.
- On going legal action or disability claim.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TMS Intervention for 5 days Transcranial Magnetic Stimulation (TMS) Application of Transcranial Magnetic Stimulation (TMS) for up to 5 days TMS Intervention for 1 day Transcranial Magnetic Stimulation (TMS) Application of Transcranial Magnetic Stimulation (TMS) for 1 day
- Primary Outcome Measures
Name Time Method Present Pain Intensity Baseline, post-treatment, one week follow-up Present pain intensity was reported by participants using a visual analog scale (VAS) from scores ranging from 1-10; lower scores represent less pain, higher scores represent more severe pain.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Palo Alto, California, United States